Literature DB >> 33936449

Validation of the Data Quality of a Tumor Board Registry Through Assessment of Clinicopathologic Survival Outcomes in Melanoma Patients.

Katherine Given Ligtenberg1,2, David Chartash3, Marcus Bosenberg1,4, Cynthia Brandt3.   

Abstract

Entities:  

Year:  2021        PMID： 33936449      PMCID： PMC8075482     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN： 1559-4076


× No keyword cloud information.
  5 in total

Review 1.  Defining and improving data quality in medical registries: a literature review, case study, and generic framework.

Authors:  Danielle G T Arts; Nicolette F De Keizer; Gert-Jan Scheffer
Journal:  J Am Med Inform Assoc       Date:  2002 Nov-Dec       Impact factor: 4.497

2.  Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.

Authors:  Emily Stamell Ruiz; Pritesh S Karia; Robert Besaw; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

4.  Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.

Authors:  Shirin Bajaj; Douglas Donnelly; Melissa Call; Paul Johannet; Una Moran; David Polsky; Richard Shapiro; Russell Berman; Anna Pavlick; Jeffrey Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

5.  Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.

Authors:  Sally Y Tan; Julie Najita; Xiaoxue Li; Lauren C Strazzulla; Haili Dunbar; Mee-Young Lee; Virginia J Seery; Elizabeth I Buchbinder; Nicholas E Tawa; David F McDermott; Sandra J Lee; Michael B Atkins; Caroline C Kim
Journal:  Melanoma Res       Date:  2019-02       Impact factor: 3.599
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.